CorMedix Inc. (CRMD)
NASDAQ: CRMD · Real-Time Price · USD
12.53
+0.45 (3.68%)
Aug 14, 2025, 2:10 PM - Market open
CorMedix Market Cap
CorMedix has a market cap or net worth of $934.98 million as of August 14, 2025. Its market cap has increased by 263.52% in one year.
Market Cap
934.98M
Enterprise Value
711.48M
1-Year Change
263.52%
Ranking
Category
Stock Price
$12.53
Market Cap Chart
Since May 13, 2010, CorMedix's market cap has increased from $34.20M to $934.98M, an increase of 2,633.86%. That is a compound annual growth rate of 24.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 901.80M | 83.48% |
| Dec 31, 2024 | 491.50M | 138.48% |
| Dec 29, 2023 | 206.10M | 18.31% |
| Dec 30, 2022 | 174.20M | 0.52% |
| Dec 31, 2021 | 173.30M | -27.40% |
| Dec 31, 2020 | 238.70M | 27.78% |
| Dec 31, 2019 | 186.80M | 37.45% |
| Dec 31, 2018 | 135.90M | 304.46% |
| Dec 29, 2017 | 33.60M | -45.72% |
| Dec 30, 2016 | 61.90M | -13.79% |
| Dec 31, 2015 | 71.80M | 67.76% |
| Dec 31, 2014 | 42.80M | 114.00% |
| Dec 31, 2013 | 20.00M | 143.90% |
| Dec 31, 2012 | 8.20M | 156.25% |
| Dec 30, 2011 | 3.20M | -84.62% |
| Dec 31, 2010 | 20.80M | -39.18% |
View and export this data all the way back to 2010.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 574.04B |
| Johnson & Johnson | 416.11B |
| AbbVie | 350.91B |
| UnitedHealth Group | 236.90B |
| AstraZeneca | 232.33B |
| Novartis AG | 230.64B |
| Abbott Laboratories | 228.03B |
| Novo Nordisk | 223.00B |